Echocardiography Guided TAVR (Echo TAVR)

NCT07030062 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2025-06-19

No results posted yet for this study

Summary

Conventional transcatheter aortic valve replacement (TAVR) relies on fluoroscopic and contrast agents. However, in high-risk patients, exposure to ionizing radiation and contrast agents is contraindicated and undesirable. Echocardiography guidance TAVR can offer a feasible and safer strategy for TAVR.

Conditions

  • Transcatheter Aortic Valve Replacemen
  • Echocardiography

Sponsors & Collaborators

  • Pan Xiangbin

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-02-18
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07030062 on ClinicalTrials.gov